Effects Appetite stimulant Indications Loss of appetite Active ingredients By cause: herbal bitter agents and spices: E.g. wormwood, ginger, take half an hour before meals. Prokinetics: Metoclopramide (Paspertin). Domperidone (Motilium) Antihistamines and anticholinergics: Pizotifen (Mosegor, out of commerce), cyproheptadine (out of commerce in many countries). Antidepressants: E.g. mirtazapine, caution: some antidepressants such as the SSRIs … Appetite Stimulants
Products Altrenogest is marketed as a solution for administration as a veterinary drug. It has been approved in many countries since 2006. Structure and properties Altrenogest (C21H26O2, Mr = 310.4 g/mol) is a derivative of progesterone. Effects Altrenogest (ATCvet QG03DX90) reduces the secretion of LH and FSH. Indications Altrenogest is used in gilts to synchronize … Altrenogest
Products Vaginal (contraceptive ring): NuvaRing (+ ethinyl estradiol) see under contraceptive ring. Implanted (plastic rods): Implanon Structure and properties Etonogestrel (3-keto-desogestrel, C22H28O2, Mr = 324.5 g/mol) is the biologically active metabolite of desogestrel (Cerazette), a progestin derived from 19-nortestosterone. Effects The contraceptive effects of etonogestrel (ATC G03AC08) are primarily due to inhibition of ovulation. Indications … Etonogestrel
Products Dienogest is commercially available in many countries as a fixed combination with estradiol valerate in tablet form (Qlaira). Furthermore, a monopreparation for endometriosis therapy is available (Visanne, see under Dienogest Endometriosis). The fixed combination with ethinyl estradiol (Valette, generic) was approved in many countries in 2014. Dienogest + estradiol Qlaira has been on the … Dienogest
Products Dienogest is commercially available for endometriosis therapy in tablet form (Visanne, generic). Structure and properties Dienogest (C20H25NO2, Mr = 311.4 g/mol) is a derivative of 19-nortestosterone (nandrolone) and carries a cyanomethyl group. Effects Dienogest (ATC G03DB08) has progestogenic and antiandrogenic properties. The effects are due to selective binding to progesterone receptors. Dienogest abolishes the … Dienogest (Endometriosis Therapy)
Products Progesterone gel Progestogel for the treatment of mastodynia has been approved in many countries since 1980. Structure and properties Progesterone (C21H30O2, Mr = 314.5 g/mol) exists as a white crystalline powder or as colorless crystals and is practically insoluble in water. It corresponds in structure and properties to the natural sex hormone. Effects Progesterone … Progesterone Gel
Products Cyproterone acetate is commercially available in the form of dragées in combination with ethinyl estradiol (generics). The drug has been approved in many countries since 1987. This article refers to the original Diane-35 and corresponding generics. Other drugs containing cyproterone acetate are available for other indications. Bayer’s original Diane-35 goes off the market in … Cyproterone Acetate
Products Progesterone is commercially available as a vaginal gel, a gel, in capsule form, and as a solution for injection. The capsules can be used orally and vaginally. Progesterone has been approved in many countries since 1955. Structure and properties Progesterone (C21H30O2, Mr = 314.5 g/mol) exists as a white crystalline powder or colorless crystals … Progesterone Hormone
Products Mifepristone is commercially available in tablet form (Mifegyne). It was first approved in 1988 and in many countries in 1999. Mifepristone was discovered in the 1980s at Roussel-Uclaf (RU) during the development of antiglucocorticoid agents and is therefore also known as RU 486. Structure and properties Mifepristone (C29H35NO2, Mr = 429.6 g/mol) is a … Mifepristone
Symptoms The most common symptoms include cramping or dull abdominal pain. In addition, numerous other symptoms may occur, such as headache, menstrual migraine, back pain, pain in the legs, loss of appetite, nausea and vomiting, diarrhea, weakness, dizziness, flushing of the skin, flushing, sleep disturbances, mood swings, depression, irritability, and nervousness. The symptoms first appear … Menstrual Cramps
Products Duogynon was approved in Germany between 1950 and 1981 in the form of dragées and as an intramuscular solution for injection. It was manufactured by Schering AG, which was acquired by Bayer in 2006. Duogynon was later renamed Cumorit. The drug was also approved in other countries, including the United Kingdom, where it was … Duogynon
Products Dydrogesterone is commercially available in the form of film-coated tablets (Duphaston, fixed combination with estradiol: Femoston conti). It has been approved in many countries since 1963. Structure and properties Dydrogesterone (C21H28O2, Mr = 312.4 g/mol) Effects Dydrogesterone (ATC G03DB01) has gestagenic properties. Indications Hormone replacement therapy in combination with an estrogen (menopause, ovariectomy). Cycle … Dydrogesterone
